Ready to play
Ready to play
Alcon, the company specializing in eye care, has raised its profit forecasts for 2026 after downgrading its estimates of the impact of tariffs from $100-150 million to $40-90 million, factoring in a potential $60 million refund from the U.S. government. The company noted that growth in equipment sales and new products, along with price increases, helped support its results, with the United States accounting for 45% of its sales in the first half of the year. Alcon forecasted that its core operating profit margin would increase by 90 to 190 basis points, and that earnings per share would grow between 12% and 15%. In the second quarter, its sales reached $2.78 billion, surpassing analyst expectations, while its net sales for 2025 totaled $10.3 billion, with $990 million invested in research and development as part of its strategy to innovate and introduce new products in the eye care field.
Notice: This Is an AI-Generated Summary
Comments (0)